Study of Rule-Based Algorithms in Anemia Management in Prevalent Hemodialysis Patients and Its Relation to Patients' Outcomes
NCT06996717 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 145
Last updated 2025-05-30
Summary
The study will assess role of rule based algorithm in anemia management in hemodialysis patients and its relation to patient's mortality
Conditions
- Anemia in End Stage Renal Disease
Interventions
- DRUG
-
ESA
anemia management algorithm will successfully increase the number of patients in the target hemoglobin range
Sponsors & Collaborators
-
Ain Shams University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-01
- Primary Completion
- 2025-06-30
- Completion
- 2025-06-30
Countries
- Egypt
Study Locations
More Related Trials
-
Use of a Novel Artificial Intelligence Assisted Platform to Assess Optimal Dosing and Treatment Strategy of Erythropoiesis-stimulating Agents (ESA) in Hemodialysis Patients
NCT05032651 ·Status: UNKNOWN ·Phase: NA
-
" Evaluation of Erythropoietin Therapy in Patients With End-Stage Kidney Disease on Regular Hemodialysis: Hemoglobin Outcomes, and Metabolic Syndrome as a Risk Factor for Erythropoietin Resistance "
NCT06983756 ·Status: NOT_YET_RECRUITING
-
An Observational Study of Epoetin Beta [Neorecormon] to Evaluate the Quality of Life in Patients on Dialysis With Chronic Renal Anemia
NCT01105494 ·Status: COMPLETED
-
Does Oral Pentoxifylline Administration Improve Hemoglobin in Hemodialysis Patients?
NCT03731741 ·Status: COMPLETED ·Phase: PHASE2
-
Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis
NCT02185911 ·Status: COMPLETED
-
The Effect on Vascular Reactivity Using the Erythropoeitin Alpha on Incident Peritoneal Dialysis Patients
NCT03286712 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison Among Erythropoietin Stimulating Agents
NCT02049346 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis
NCT00096915 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Adding Lactoferrin on Oral Iron on Anemia in Chronic Kidney Disease Patients
NCT05900635 ·Status: UNKNOWN ·Phase: PHASE4
-
Renal Prognosis in Chronic Kidney Disease Patients With Hyporesponsive Anemia to Erythropoiesis Stimulating Agents
NCT02136563 ·Status: COMPLETED
-
Renal Anemia Refractory to Erythropoietin
NCT03480178 ·Status: UNKNOWN
-
A Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia
NCT02952092 ·Status: COMPLETED ·Phase: PHASE3
-
Epoetin Dosing Regimens in Haemodialysis
NCT00349960 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan
NCT03439137 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia.
NCT00440063 ·Status: TERMINATED ·Phase: PHASE4
-
Prospective Observational Study of Erythropoietin-Iron Interaction in Anemia of Renal Disease
NCT01719146 ·Status: COMPLETED
-
A Study of the Safety and Efficacy of Long-term Correction of Anemia With Epoetin Alfa in Early Hemodialysis Patients
NCT00261521 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Pentoxifylline on Anemia in Hemodialysis Patients
NCT05708248 ·Status: UNKNOWN ·Phase: NA
-
A Study of Once Monthly Subcutaneous Mircera in Dialysis Patients With Chronic Renal Anemia
NCT00882713 ·Status: COMPLETED ·Phase: PHASE3
-
Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis Patients
NCT00233597 ·Status: COMPLETED ·Phase: PHASE3
-
Cost Utility Analysis of Erythropoietin for Anemia Treatment in Hemodialysis Patients
NCT01049711 ·Status: COMPLETED
-
A Retrospective Observational Study of Hemoglobin Levels in Patients With Renal Anemia Treated With Mircera (Methoxy Polyethylene Glycol-Epoetin Beta)
NCT01379963 ·Status: COMPLETED
-
Intravenous Versus Oral Iron Therapy in Hemodialysis Patients
NCT04464850 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of SAL-0951 Compared to Recombinant Human Erythropoietin in Anemic Patients Receiving Maintenance Hemodialysis
NCT06720025 ·Status: COMPLETED ·Phase: PHASE3
-
Safety & Efficacy of Pegolsihematide for Treatment of Anemia in Participants on Dialysis
NCT02586402 ·Status: UNKNOWN ·Phase: PHASE2